Bioventus Inc - Ordinary Shares - Class A
BVS
Market Cap$486.13M
Close$
$5.23
23.1% downside
Current Fair Value
23.1% downsideOvervalued by 23.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $486.13 Million |
|---|---|
| Enterprise Value | $475.76 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.75 |
| Beta | 0.92 |
| Outstanding Shares | 65,451,881 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -14.32 |
|---|---|
| PEG | 42.19 |
| Price to Sales | 0.85 |
| Price to Book Ratio | 3.4 |
| Enterprise Value to Revenue | 0.86 |
| Enterprise Value to EBIT | 22.25 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bioventus Inc
700 employeesBioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioven...